|
|
|
|
|
|
|
Vertex Pharmaceutic (VRTX)
|
|
157.5 0.53 (0.34%)
|
05-25 16:00
|
|
Open:
|
157
|
Pre. Close:
|
156.97
|
|
High:
|
157.9
|
Low:
|
156.22
|
|
Volume:
|
560,980
|
Market Cap:
|
40136M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
158.015 - 158.764
|
158.764 - 159.468
|
|
Low:
|
154.267 - 155.145
|
155.145 - 155.97
|
|
Close:
|
156.078 - 157.439
|
157.439 - 158.717
|
|
|
|
Technical analysis (as of: 2018-05-25 4:40:33 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 187.87 One year: 219.44
|
|
Support:
|
Support1: 151.54 Support2: 145.78
|
|
Resistance:
|
Resistance1:
160.85 Resistance2: 187.87
|
|
Pivot:
|
154.70
|
|
Moving Averages:
|
MA(5): 156.79 MA(20): 153.73
MA(100): 160.63 MA(250): 151.85
|
|
MACD:
|
MACD(12,26):
-0.06 Signal(12,26,9): -0.84
|
|
%K %D:
|
%K(14,3): 89.18 %D(3): 86.61
|
|
RSI:
|
RSI(14): 53.82
|
|
52-Week:
|
High: 178.15
Low: 118.05 Change(%): 30.8
|
|
Average Vol(K):
|
3-Month: 145069
10-Days 100775
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.VRTX has closed below upper band by 28.4%. Bollinger Bands are 25.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-18T08:21:17-04:00
Investors bullish on biotechs after Trump drug pricing speech
2018-05-17T13:02:04-04:00
Avalara Files To Raise $150 Million In U.S. IPO
2018-05-11T14:25:19-04:00
Trump speech on drug prices light on specifics
2018-05-11T10:22:19-04:00
Trump plan on drug prices to be announced this afternoon
2018-05-09T01:40:03-04:00
Biotech Analysis Central Pharma News: Takeda's Acquisition Win, Ionis And Akcea Tumble, Alnylam's Advance In CNS
2018-05-04T03:18:51-04:00
Institutional Top Ideas Series: Orbimed Advisors
2018-05-02T06:00:17-04:00
The Old Faithful Portfolio
2018-05-01T08:30:00-04:00
Vertex Awards $400,000 in Scholarships to People Living with Cystic Fibrosis and Their Immediate Family Members
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
